本页面由Tiger Trade Technology Pte. Ltd.提供服务

4D Molecular Therapeutics

10.06
+0.29002.97%
盘后10.00-0.0563-0.56%18:46 EDT
成交量:83.71万
成交额:821.22万
市值:5.13亿
市盈率:-4.16
高:10.10
开:9.75
低:9.53
收:9.77
52周最高:12.34
52周最低:2.88
股本:5,100.79万
流通股本:3,678.36万
量比:1.17
换手率:2.28%
股息:- -
股息率:- -
每股收益(TTM):-2.4186
每股收益(LYR):-2.4200
净资产收益率:-27.57%
总资产收益率:-17.34%
市净率:1.01
市盈率(LYR):-4.16

数据加载中...

2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/17

重要事件披露

Form 8-K - Current report
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]